Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: York, Pennsylvania 25 trials found
New Search
Filter
Trial Phase
Study Type
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
PHASE2INTERVENTIONAL Jonesboro, Arkansas +4 more
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
PHASE1, PHASE2INTERVENTIONAL Santa Rosa, California +4 more
RECRUITING
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
PHASE3INTERVENTIONAL Fayetteville, Arkansas +4 more
RECRUITING
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
PHASE3INTERVENTIONAL Little Rock, Arkansas +4 more
RECRUITING
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy
NAINTERVENTIONAL Buffalo, New York +2 more
RECRUITING
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
PHASE2INTERVENTIONAL Tampa, Florida +4 more
RECRUITING
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
PHASE1, PHASE2INTERVENTIONAL Cerritos, California +4 more
RECRUITING
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
NAINTERVENTIONAL Burlington, Massachusetts +3 more
RECRUITING
Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
PHASE1, PHASE2INTERVENTIONAL Hershey, Pennsylvania
RECRUITING
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
PHASE4INTERVENTIONAL Chicago, Illinois +2 more
RECRUITING
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
PHASE2INTERVENTIONAL Mesa, Arizona +4 more
RECRUITING
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
N/AOBSERVATIONAL Anchorage, Alaska +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type